The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effectiveness of adjuvant FOLFOX versus 5FU for colon cancer treatment in community oncology practice using a hybrid study approach.
 
Jennifer Leigh Lund
Employment - GlaxoSmithKline (I)
Stock and Other Ownership Interests - GlaxoSmithKline (I)
Research Funding - Abbvie (Inst)
 
Michael Webster-Clark
Other Relationship - UNC Center for Pharmacoepidemiology
 
Alexander P Keil
No Relationships to Disclose
 
Daniel Westreich
No Relationships to Disclose
 
Til Sturmer
Stock and Other Ownership Interests - AstraZeneca; BASF; Novartis; Novo Nordisk; Roche
Consulting or Advisory Role - UNC Center for Pharmacoepidemiology
Research Funding - Novo Nordisk (Inst); Sanofi (Inst)
 
Hanna Kelly Sanoff
Research Funding - Bayer (Inst)